Ed joined HLM as a partner in 2000. He was a founding partner of Cahill, Warnock & Company (now Camden Partners), a Baltimore venture capital firm, and a Managing Director of Alex. Brown & Sons, where he headed the firm’s Healthcare group from 1986 to 1995. During his leadership at Alex. Brown & Sons, he and his team underwrote public offerings or provided merger advisory services for over 200 healthcare companies, including the first publicly-held managed care, outpatient surgery center, rehabilitation, behavioral health and digital health companies and numerous pioneering biopharmaceutical and medical technology innovators.

Ed is a director of Blue Rabbit, Carevive Systems, Persivia, and Phreesia (NYSE:PHR). He is an observer for Aktana, and a Special Adviser to DermTech (NaSDaQ: DMTK). He previously served as a director of numerous companies, including Animas Corporation (acquired by J&J), Centene Corporation (NYSE), Masimo Corporation (NASDAQ), Tandem Diabetes (NASDAQ), TYRX (acquired by Medtronic) and Vets First Choice (now Covetrus : NASDAQ:CVET).

He is a Trustee of Mercy Health Services and a Trustee Emeritus of Johns Hopkins Medicine and Johns Hopkins Health System.

Ed received an AB from Williams College and a Master of Public and Private Management degree from Yale University. He lives with his wife, Kate, in Dedham, Massachusetts.

Vin is a director at Array Behavioral, Censinet and ClearDATA Networks, and a board observer at Carevive Systems, Hazel Health, meQuilibrium, and Persivia.

Sophie joined HLM in November 2021 and is involved in all aspects of the investment process, including sourcing, due diligence, transaction execution and portfolio company support.

Prior to joining HLM, Sophie was an Associate at Goldman Sachs where she spent four years in the Investment Banking Division, advising clients across industries. She earned her BA in 2017 from Yale University where she was a member of the Yale Women’s Lacrosse team. Sophie’s passion for healthcare extends beyond the workplace and she is currently on the board of the Corey C. Griffin Foundation, which supports the health and development of children in the Boston area.

Peter has been a managing partner at HLM for over 30 years. His investment activity has focused on innovative healthcare services and digital health technology companies. Peter is currently a director of: Evolent Health (NYSE), Linkwell Health, meQuilibrium, MyTown Health, Oceans Healthcare, and Vaxcare. Previously, he was a director of several HLM portfolio companies including: Actamed (acquired by WebMD), ArroHealth (acquired by CIOX), Casenet (acquired by Centene), Innovacare Health (recapitalized by Bain Capital), MedVentive (acquired by McKesson), Medicalis (acquired by Siemens Healthineers), Nordic Consulting (recapitalized by Silversmith), Onshift (acquired by Shiftkey), Silverlink Communications (acquired by Welltok). Also, he served on the public company boards of: Atria Communities (NASDAQ acquired by Lazard Freres Real Estate Investors), Renal Care Group (NYSE acquired by Fresenius Medical Care), The Advisory Board (NASDAQ acquired by Optum) and WellTower (aka Health Care REIT—NYSE).

Prior to joining HLM in 1992, Peter was a Managing Director of Alex. Brown & Sons, where he directed research in healthcare services and managed care. Previously, he was a research analyst at William Blair & Company and a strategy consultant at Booz Allen Hamilton.

Peter received an AB from Bowdoin College and an MBA from Columbia University.

Michael joined HLM as a Partner in 2024. Michael joins from MTS Health Partners (MTS), a leading healthcare focused boutique investment bank, where he was a Partner that led the firm’s healthcare technology coverage, focused on mergers, acquisitions, and capital raising transactions. While at MTS, Michael also founded Elements Health Ventures, a venture capital firm focused on early and growth stage healthcare technology and technology-enabled services companies.

Prior to joining MTS in 2012, Michael worked at Health Enterprise Partners (HEP), a private equity firm focused on healthcare technology and healthcare services investments. Previously, Michael worked at Aetna in the Corporate Strategy group, and he started his career at The Lewin Group, a strategy consulting firm focused on healthcare.

Michael received a Bachelor’s degree in Economics from Tufts University, MPH from the Columbia University Mailman School of Public Health, and MBA from Columbia Business School.

Dr. Mayer joined HLM as a Partner in 2024. He has spent the last 15 years as a clinician (psychiatrist), healthcare executive/entrepreneur, and investor. He has accrued a unique blend of provider, payer, and technology operational and investment experience. Most recently, Dr. Mayer served as the President and Board Director of onehome, a leading care-in-the-home provider and payer-services company, for over four-years after sourcing and leading the investment into the company in 2017. In his role as President, he oversaw the company’s operations, through its sale to Humana in 2021 and its subsequent expansion and integration following the acquisition. In addition to his role at onehome, he has worked extensively advising and operating companies working at the intersection of post-acute care, home-based services, and Medicare Advantage.

Previously, Dr. Mayer founded Cureatr and as CEO, built it into a leading venture-backed healthcare technology company delivering value-based solutions around real-time data exchange to support care transitions, medical management, and provider communication. Prior to Cureatr, Dr. Mayer trained as a psychiatrist at the Mount Sinai Medical Center in New York City.

Dr. Mayer holds a B.S. in Biological Sciences from Stanford University and an M.D. from Columbia University College of Surgeons and Physicians. Crain’s recognized his achievements through the Crain’s 40 Under 40 Award in 2016.

Satyam joined HLM in June 2024 and is actively involved in all aspects of our investment process and portfolio company support. Prior to joining HLM, he was an Analyst at Cain Brothers, a healthcare focused investment bank. He earned his B.S. in Finance from the Ohio State University.

Enrico is a pioneer in the life sciences with a history of recognizing and developing new technologies that move markets. He is currently a director of HealthEC, U.S. Medical Management, and Wayspring, and a board observer at Ascellus, b.well Connected Health, Blue Rabbit Ventures, mPulse Mobile, nirvanaHealth and OnShift. His previous board appointments included AbleTo (recapped), Spinal Kinetics (Sold to Orthofix), Transcend Medical (sold to Alcon), LetsGetChecked, Medicalis (Sold to Siemens), Aventura (sold to Philips), SensAble Technologies (sold to 3D Systems) and was a board observer and special advisor to Interlace Medical (sold to Hologic) and Tandem Diabetes (NASDAQ; TNDM).

Prior to joining HLM as a Venture Partner, Enrico co-founded HTS Biosystems, Inc., an early developer of platforms for drug discovery and point of care diagnostics, where he served as Chief Operating Officer and Chief Technology Officer. Prior to HTS, Enrico held leadership positions with PerkinElmer, Inc. and Applied Biosystems, Inc. At Applied Biosystems, Enrico was one of the major forces behind the development and commercialization of PCR, the revolutionary DNA-replicating technology that enabled the development of some of the most significant advancements in molecular biology and diagnostics.

Enrico is the holder of nine patents and has been recognized by the Smithsonian Institute for his achievements in PCR. He is the author of numerous scientific papers and has been a frequent domestic and international speaker.

Enrico attended the University of Connecticut for undergraduate and post graduate studies.

Mike joined HLM in 2007 and was promoted to CFO in 2015. He provides the team with legal and diligence support and is responsible for the financial and administrative functions of the firm. Prior to joining HLM, he was a Financial Analyst at Summit Partners and a Senior Auditor at Deloitte. Mike received a BSBA in Accounting and Finance from Boston University and an MBA in Finance from Boston College. He is also a Certified Public Accountant.

Audrey joined HLM in 1996. As HLM’s IT Manager, she oversees all aspects of the firm’s technologies, systems, infrastructure and data security. Audrey holds a B.A. from the University of Massachusetts.

Bobby joined HLM in 2022 to support its financial and operational initiatives. Prior to joining HLM, he was a Senior Audit Associate for KPMG’s Boston asset management practice. Bobby received a BS in Accountancy from Bentley University and a Master’s degree in Accounting & Data Analytics from Villanova School of Business.